{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:46:16Z","timestamp":1792565176706,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.forsciint.2026.113143","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:16:02Z","timestamp":1789830962000},"page":"113143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Medical and non\u2011medical gabapentinoid use in fatal drug poisonings in Norway: Linked postmortem toxicology and prescription data"],"prefix":"10.1016","volume":"389","author":[{"given":"Elen","family":"Bodal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Marie Temte","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1805-5221","authenticated-orcid":false,"given":"Thomas","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde Marie Er\u00f8y","family":"Edvardsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Skurtveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-9014","authenticated-orcid":false,"given":"Stig Tore","family":"Bogstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7223-6731","authenticated-orcid":false,"given":"Anna Armika Tussilago","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2026.113143_bib1","unstructured":"The Norwegian Institute of Public Health. Norwegian Prescribed Drug Registry: Drug statistics per ATC code [Original title: Legemiddelstatistikk per ATC-kode] (n.d.) [26 June 2026]. Available from: https:\/\/statistikk.fhi.no\/lmr\/kVQEwOzJ4-ArMo6deK1PITb0wg9-JWHY?Atc_Verdi=N02BF01,N02BF02&Kjonn_Verdi=TOTALT&Aldersgruppe_Verdi=TOTALT&Utlevering_Ar=2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023,2024,2025&MEASURE_TYPE=Brukere_Per1000_Innbyggere&DIAGRAM_TYPE=table. .."},{"key":"10.1016\/j.forsciint.2026.113143_bib2","unstructured":"The Norwegian Medicines Manual for Health Personnel. Gabapentin, Pregabalin. 2023 [2 May 2025]. Available from: https:\/\/www.legemiddelhandboka.no\/."},{"issue":"2","key":"10.1016\/j.forsciint.2026.113143_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/2049463720912496","article-title":"Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice","volume":"14","author":"Chincholkar","year":"2020","journal-title":"Br. J. Pain."},{"issue":"4","key":"10.1016\/j.forsciint.2026.113143_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.18773\/austprescr.2023.025","article-title":"Gabapentinoids: a therapeutic review","volume":"46","author":"Athavale","year":"2023","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.forsciint.2026.113143_bib5","article-title":"Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?","volume":"12","author":"Peckham","year":"2018","journal-title":"Subst. Abus."},{"issue":"1","key":"10.1016\/j.forsciint.2026.113143_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures","volume":"45","author":"Arroyo","year":"2004","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.forsciint.2026.113143_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/jat\/bkaf005","article-title":"Pregabalin concentrations: establishing 'normal' and 'cause for concern' concentration ranges in postmortem blood","volume":"49","author":"Nahar","year":"2025","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.forsciint.2026.113143_bib8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.forsciint.2026.113143_bib9","unstructured":"Al-Swafi F. Gabapentin [Original title: Gabapentin i Store medisinske leksikon] 2025 [2 May 2025]. Available from: https:\/\/sml.snl.no\/gabapentin."},{"issue":"2","key":"10.1016\/j.forsciint.2026.113143_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B","article-title":"3-substituted GABA analogs with central nervous system activity: a review","volume":"19","author":"Bryans","year":"1999","journal-title":"Med. Res. Rev."},{"issue":"10","key":"10.1016\/j.forsciint.2026.113143_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.forsciint.2026.113143_bib12","first-page":"46","article-title":"Side effect reporting is useful: pregabalin has been reclassified to prescription group B [Original title: Bivirkningsrapportering nytter: pregabalin er flyttet til reseptgruppe B]","volume":"47","author":"Nordmo","year":"2018","journal-title":"Utposten"},{"issue":"1","key":"10.1016\/j.forsciint.2026.113143_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40263-015-0303-6","article-title":"Abuse Potential of Pregabalin: A Systematic Review","volume":"30","author":"Schjerning","year":"2016","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.forsciint.2026.113143_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/j.pain.0000000000003453","article-title":"Pregabalin is associated with a higher overdose risk but the risk with gabapentin is not negligible","volume":"166","author":"Hamina","year":"2025","journal-title":"Pain"},{"key":"10.1016\/j.forsciint.2026.113143_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-026-02342-w","article-title":"Misuse of Pregabalin and Gabapentin: A Second Systematic Review Update","author":"Evoy","year":"2026","journal-title":"Drugs"},{"key":"10.1016\/j.forsciint.2026.113143_bib16","article-title":"Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study","volume":"27","author":"Ashworth","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.forsciint.2026.113143_bib17","series-title":"Annual report on the state of the drugs problem in Europe","year":"2010"},{"issue":"7","key":"10.1016\/j.forsciint.2026.113143_bib18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40263-016-0359-y","article-title":"A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database","volume":"30","author":"Chiappini","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.forsciint.2026.113143_bib19","unstructured":"National Institute on Drug Abuse. Misuse of prescription drugs research report 2011 [15 December 2025]. Available from: https:\/\/nida.nih.gov\/publications\/research-reports\/misuse-prescription-drugs\/overview."},{"key":"10.1016\/j.forsciint.2026.113143_bib20","unstructured":"Jamt R.E.G., Edvardsen H.M.E., Dugstad K.U., Middelkoop G. Findings in blood samples from suspected DUI cases in 2024 [Original title: Funn i blodpr\u00f8ver hos bilf\u00f8rere mistenkt for rusp\u00e5virket kj\u00f8ring 2024]: Oslo University Hospital; 2025 [15 December 2025]. Available from: https:\/\/www.oslo-universitetssykehus.no\/49d3dd\/contentassets\/0b1e5e1ae18041dbaf870ce2f946ff07\/rusmiddelstatistikk-bilforere---funn-i-blodprover-hos-bilforere-mistenkt-for-ruspavirket-kjoring-2024.pdf."},{"key":"10.1016\/j.forsciint.2026.113143_bib21","unstructured":"Hagelien M.V.R., Havig S.M., Middelkoop G., Edvardsen H.M.E. Autopsy statistics. Findings in blood samples from autopsies conducted in 2025 [Original title: Obduksjonsstatistikk. Toksikologiske funn i blodpr\u00f8ver fra obduksjoner utf\u00f8rt i 2025]: Oslo University Hospital; 2026 [18 June 2026]. Available from: https:\/\/www.oslo-universitetssykehus.no\/49833e\/contentassets\/0b1e5e1ae18041dbaf870ce2f946ff07\/obduksjonsstatistikk-for-2025_publiseres.pdf."},{"key":"10.1016\/j.forsciint.2026.113143_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109281","article-title":"Opioid related deaths in Norway in 2000-2019","volume":"232","author":"Edvardsen","year":"2022","journal-title":"Drug. Alcohol. Depend."},{"key":"10.1016\/j.forsciint.2026.113143_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsir.2025.100408","article-title":"Fatal poisonings in Nordic countries in 2022 among people who use drugs","volume":"11","author":"Kriikku","year":"2025","journal-title":"Forensic Science International Reports"},{"issue":"2","key":"10.1016\/j.forsciint.2026.113143_bib24","article-title":"Toxicological findings in overdose suicides 2016-21","volume":"145","author":"Nyman","year":"2025","journal-title":"Tidsskr. Nor. Laege"},{"issue":"8","key":"10.1016\/j.forsciint.2026.113143_bib25","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1111\/bcp.15352","article-title":"Fatalities associated with gabapentinoids in England (2004-2020)","volume":"88","author":"Kalk","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2026.113143_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110830","article-title":"Pregabalin and gabapentin in non-opioid poisoning deaths","volume":"324","author":"Kriikku","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2026.113143_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.forsciint.2016.03.028","article-title":"Gabapentin concentrations and postmortem distribution","volume":"262","author":"Hamm","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"3","key":"10.1016\/j.forsciint.2026.113143_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jat\/bku004","article-title":"Quantification of pregabalin using hydrophilic interaction HPLC-high-resolution MS in postmortem human samples: eighteen case reports","volume":"38","author":"Priez-Barallon","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113143_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jchromb.2012.12.039","article-title":"Quantitative determination of fifteen basic pharmaceuticals in ante- and post-mortem whole blood by high pH mobile phase reversed phase ultra high performance liquid chromatography-tandem mass spectrometry","volume":"927","author":"Amundsen","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.forsciint.2026.113143_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jchromb.2011.12.009","article-title":"Determination of gamma-hydroxybutyrate (GHB), beta-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and gamma-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS","volume":"885-886","author":"Dahl","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.forsciint.2026.113143_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchromb.2014.09.018","article-title":"Quantitative determination of zopiclone and zolpidem in whole blood by liquid-liquid extraction and UHPLC-MS\/MS","volume":"971","author":"Eliassen","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"6","key":"10.1016\/j.forsciint.2026.113143_bib32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jat\/bkab071","article-title":"Methadone, Buprenorphine, Oxycodone, Fentanyl and Tramadol in Multiple Postmortem Matrices","volume":"46","author":"Havig","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.forsciint.2026.113143_bib33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jat\/bky030","article-title":"Comparative Study of Postmortem Concentrations of Antidepressants in Several Different Matrices","volume":"42","author":"Oiestad","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.forsciint.2026.113143_bib34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/anatox\/35.5.280","article-title":"Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"35","author":"Oiestad","year":"2011","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113143_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jchromb.2011.10.033","article-title":"Determination of benzodiazepines in ante-mortem and post-mortem whole blood by solid-supported liquid-liquid extraction and UPLC-MS\/MS","volume":"883-884","author":"Sauve","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.forsciint.2026.113143_bib36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jat\/bkaa108","article-title":"Quantitative Determination of Ethyl Glucuronide and Ethyl Sulfate in Postmortem and Antemortem Whole Blood Using Phospholipid Removal 96-Well Plate and UHPLC-MS-MS","volume":"45","author":"Sidqey","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113143_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-025-03897-5","article-title":"The role of prescribed opioids in Norwegian overdose deaths in 2005-2021","author":"Edvardsen","year":"2025","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2026.113143_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.legalmed.2011.02.002","article-title":"Concentration ratios of free-morphine to free-codeine in femoral blood in heroin-related poisoning deaths","volume":"13","author":"Jones","year":"2011","journal-title":"Leg. Med."},{"key":"10.1016\/j.forsciint.2026.113143_bib39","series-title":"Use R!","isbn-type":"print","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","article-title":"ggplot2","author":"Wickham","year":"2016","ISBN":"https:\/\/id.crossref.org\/isbn\/9783319242750"},{"issue":"2","key":"10.1016\/j.forsciint.2026.113143_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2020.05.017","article-title":"Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland","volume":"125","author":"Torrance","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.forsciint.2026.113143_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112669","article-title":"Harms associated with prescription drug misuse in Ireland: A national observational study of trends in treatment demand, non-fatal intentional drug overdoses and drug related deaths 2010-2020","volume":"272","author":"Durand","year":"2025","journal-title":"Drug. Alcohol. Depend."},{"issue":"7","key":"10.1016\/j.forsciint.2026.113143_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40263-016-0359-y","article-title":"A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency\u2019s \u2018Suspected Adverse Drug Reactions\u2019 Database","volume":"30","author":"Chiappini","year":"2016","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.forsciint.2026.113143_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update","volume":"81","author":"Evoy","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.forsciint.2026.113143_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.676224","article-title":"Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries","volume":"12","author":"Fonseca","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"6","key":"10.1016\/j.forsciint.2026.113143_bib45","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/10826084.2025.2454653","article-title":"Assessing Prevalence of Nonmedically Used Prescription Drug Involvement in Overdose Deaths Through Linkage of State Unintentional Drug Overdose Reporting System and Controlled Substances Monitoring Program Data","volume":"60","author":"Korona-Bailey","year":"2025","journal-title":"Subst. Use Misuse"},{"issue":"7","key":"10.1016\/j.forsciint.2026.113143_bib46","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.forsciint.2026.113143_bib47","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1093\/ajhp\/zxab486","article-title":"State-level response to gabapentin misuse in the United States: Implications and future direction","volume":"79","author":"Karavolis","year":"2022","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.forsciint.2026.113143_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2018.01.018","article-title":"Prevalence of gabapentin in drug overdose postmortem toxicology testing results","volume":"186","author":"Slavova","year":"2018","journal-title":"Drug. Alcohol. Depend."},{"issue":"4","key":"10.1016\/j.forsciint.2026.113143_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bcp.15984","article-title":"Gabapentinoids in Ireland 2010\u20132020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology","volume":"90","author":"Durand","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2026.113143_bib50","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/1556-4029.14021","article-title":"Gabapentin-related Deaths: Patterns of Abuse and Postmortem Levels","volume":"64","author":"Tharp","year":"2019","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2026.113143_bib51","doi-asserted-by":"crossref","first-page":"l2147","DOI":"10.1136\/bmj.l2147","article-title":"Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden","volume":"365","author":"Molero","year":"2019","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.forsciint.2026.113143_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pain.2012.12.024","article-title":"Suicidality associated with antiepileptic drugs: implications for the treatment of neuropathic pain and fibromyalgia","volume":"154","author":"Pereira","year":"2013","journal-title":"Pain"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073826003312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073826003312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:21:57Z","timestamp":1792563717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073826003312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S0379073826003312"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2026.113143","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical and non\u2011medical gabapentinoid use in fatal drug poisonings in Norway: Linked postmortem toxicology and prescription data","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2026.113143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113143"}}